These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 29490713)

  • 1. Establishment of prophylactic enoxaparin dosing recommendations to achieve targeted anti-factor Xa concentrations in children with CHD.
    Israel EN; Thomas CA; Mastropietro CW
    Cardiol Young; 2018 May; 28(5):715-718. PubMed ID: 29490713
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-Xa guided enoxaparin dose adjustment improves pharmacologic deep venous thrombosis prophylaxis in burn patients.
    Cronin BJ; Godat LN; Berndtson AE; Pham A; Kolan S; Box K; Lee JG; Costantini TW
    Burns; 2019 Jun; 45(4):818-824. PubMed ID: 30827851
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Higher doses of low-molecular-weight heparin (enoxaparin) are needed to achieve target anti-Xa concentrations in critically ill children*.
    Schloemer NJ; Abu-Sultaneh S; Hanson SJ; Yan K; Hoffmann RG; Punzalan RC; Havens PL
    Pediatr Crit Care Med; 2014 Sep; 15(7):e294-9. PubMed ID: 24901803
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Do neonates, infants and young children need a higher dose of enoxaparin in the cardiac intensive care unit?
    Sanchez de Toledo J; Gunawardena S; Munoz R; Orr R; Berry D; Sonderman S; Krallman S; Shiderly D; Wang L; Wearden P; Morell VO; Chrysostomou C
    Cardiol Young; 2010 Apr; 20(2):138-43. PubMed ID: 20199704
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enoxaparin dose adjustment is associated with low incidence of venous thromboembolic events in acute burn patients.
    Lin H; Faraklas I; Saffle J; Cochran A
    J Trauma; 2011 Dec; 71(6):1557-61. PubMed ID: 22027887
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of Enoxaparin Dosing as a Risk Factor for Bleeding in Lung Transplant Recipients.
    Sofjan AK; Iuppa JA; Bain KB; Deal EN; Witt CA; Hachem RR; Yusen RD
    Ann Pharmacother; 2016 Oct; 50(10):824-31. PubMed ID: 27363845
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alternative dosing of prophylactic enoxaparin in the trauma patient: is more the answer?
    Kopelman TR; O'Neill PJ; Pieri PG; Salomone JP; Hall ST; Quan A; Wells JR; Pressman MS
    Am J Surg; 2013 Dec; 206(6):911-5; discussion 915-6. PubMed ID: 24296098
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Goal directed enoxaparin dosing provides superior chemoprophylaxis against deep vein thrombosis.
    Kopelman TR; Walters JW; Bogert JN; Basharat U; Pieri PG; Davis KM; Quan AN; Vail SJ; Pressman MA
    Injury; 2017 May; 48(5):1088-1092. PubMed ID: 28108019
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relation of antifactor-Xa peak levels and venous thromboembolism after trauma.
    Karcutskie CA; Dharmaraja A; Patel J; Eidelson SA; Martin AG; Lineen EB; Namias N; Schulman CI; Proctor KG
    J Trauma Acute Care Surg; 2017 Dec; 83(6):1102-1107. PubMed ID: 29190255
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Standard prophylactic enoxaparin dosing leads to inadequate anti-Xa levels and increased deep venous thrombosis rates in critically ill trauma and surgical patients.
    Malinoski D; Jafari F; Ewing T; Ardary C; Conniff H; Baje M; Kong A; Lekawa ME; Dolich MO; Cinat ME; Barrios C; Hoyt DB
    J Trauma; 2010 Apr; 68(4):874-80. PubMed ID: 20386282
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of an enoxaparin dosing calculator using burn size and weight.
    Faraklas I; Ghanem M; Brown A; Cochran A
    J Burn Care Res; 2013; 34(6):621-7. PubMed ID: 24043245
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enoxaparin Dose Requirements to Achieve Therapeutic Low-molecular-weight Heparin Anti-factor Xa Levels in Infants and Young Children.
    Wysocki EL; Kuhn A; Steinbrenner J; Tyrrell L; Abdel-Rasoul M; Dunn A; Cloyd C
    J Pediatr Hematol Oncol; 2021 Oct; 43(7):e946-e950. PubMed ID: 33512867
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel uses of insulin syringes to reduce dosing errors: a retrospective chart review of enoxaparin whole milligram dosing.
    Bauman ME; Black KL; Bauman ML; Belletrutti M; Bajzar L; Massicotte MP
    Thromb Res; 2009 Apr; 123(6):845-7. PubMed ID: 19038418
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Weight- and Anti-Xa-Guided Enoxaparin Dosing Protocol for venous thromboembolism Prophylaxis in intensive care unit Trauma Patients.
    Bigos R; Solomon E; Dorfman JD; Ha M
    J Surg Res; 2021 Sep; 265():122-130. PubMed ID: 33930618
    [TBL] [Abstract][Full Text] [Related]  

  • 15. If some is good, more is better: An enoxaparin dosing strategy to improve pharmacologic venous thromboembolism prophylaxis.
    Berndtson AE; Costantini TW; Lane J; Box K; Coimbra R
    J Trauma Acute Care Surg; 2016 Dec; 81(6):1095-1100. PubMed ID: 27244575
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adjusted value of thromboprophylaxis in hospitalized obese patients: A comparative study of two regimens of enoxaparin: The ITOHENOX study.
    Miranda S; Le Cam-Duchez V; Benichou J; Donnadieu N; Barbay V; Le Besnerais M; Delmas FX; Cuvelier A; Lévesque H; Benhamou Y; Armengol G
    Thromb Res; 2017 Jul; 155():1-5. PubMed ID: 28460259
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fluctuations of anti-Xa concentrations during maintenance enoxaparin therapy for neonatal thrombosis.
    Lulic-Botica M; Rajpurkar M; Sabo C; Tutag-Lehr V; Natarajan G
    Acta Paediatr; 2012 Apr; 101(4):e147-50. PubMed ID: 22211705
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dosing and monitoring of enoxaparin therapy in children: experience in a tertiary care hospital.
    Andrade-Campos MM; Montes-Limón AE; Fernandez-Mosteirin N; Salvador-Osuna C; Torres M; Lucia-Cuesta JF; Rubio-Felix D
    Blood Coagul Fibrinolysis; 2013 Mar; 24(2):194-8. PubMed ID: 23358201
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors influencing enoxaparin anti-Xa activity in surgical critically ill patients.
    Vincent PD; Albert M; Champagne MC; Zikos T; Boulanger I; Blais L; Williamson DR
    J Crit Care; 2011 Aug; 26(4):347-51. PubMed ID: 21454037
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retrospective evaluation of enoxaparin dosing in patients 48 weeks' postmenstrual age or younger in a neonatal intensive care unit.
    Hicks JK; Shelton CM; Sahni JK; Christensen ML
    Ann Pharmacother; 2012; 46(7-8):943-51. PubMed ID: 22828970
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.